Mary A McLaughlin, MD Email Mary McLaughlin
-
- Positions
- ASSOCIATE PROFESSOR | Medicine, Cardiology
- ASSISTANT PROFESSOR | Population Health Science and Policy
-
- Specialties
- Cardiology
- Cardiovascular Disease
-
- Languages
- English
- Spanish
-
- Hospital Affiliation
- The Mount Sinai Hospital
-
- Phone
- The Lauder Family Cardiovascular Ambulatory Center 212-241-3340212-241-3340
-
The Lauder Family Cardiovascular Ambulatory Center
1190 Fifth Avenue
1st Floor
New York, NY 10029
Phone: 212-241-3340212-241-3340
Dr. McLaughlin received her medical degree from Georgetown University School of Medicine, as a member of the Alpha Omega Alpha Medical Honor Society. She completed her internship and residency at The New York Hospital/Cornell Medical Center where she received the prestigious C. Richard Bowman award for demonstrating human warmth, scientific endeavor, and dedication to medicine. She completed her fellowship in Cardiovascular medicine at Mount Sinai School of Medicine, where she received the B. Chaus Scholar Cardiology Award, and concomitantly completed her Master's in Public Health degree at Columbia University School of Public Health. Currently, she is an Assistant Professor in the Departments of Medicine, Health Policy and Geriatrics and Adult Development. She is the Medical Director of the Cardiac Health Program, and Co-Director of the Women's Cardiac Assessment and Risk Evaluation Program.
Dr. McLaughlin is the recipient of grants from the Agency for Health Care Quality and Research, the American Heart Association, the American College of Cardiology, and the New York Academy of Medicine. Her research focuses on improving the cardiovascular care of women, elderly and minorities. She has published numerous articles in peer-reviewed journals, and is the author of four book chapters, and is on the Editorial board of the publication, "Focus on Healthy Aging." She has been an invited speaker both nationally and internationally.
Since completion of her academic training, Dr. McLaughlin has been the recipient of numerous awards, including: the American College of Cardiology/Merck Fellowship Award, the Mary and David Hoar Fellowship of the New York Academy of Medicine, the SmithKline Beecham Development Partners Junior Faculty Award in Cardiology, and the Arthur Ross Foundation Award.
In the NewsDr. McLaughlin and her work were recently profiled in The Daily News feature The Daily Check Up. View PDF.
Dr. McLaughlin discusses women's heart health in The Daily News feature The Daily Check Up.
Certification
Cardiovascular Disease
Clinical Focus
- Cardiomyopathy
- Cardiovascular Disease
- General Cardiology
- Heart Attack/Acute Coronary Syndrome
- Hyperlipidemia/High Cholesterol
- Metabolic Syndrome
- Mitral Valve Disease
- Pericarditis
- Sleep Apnea
- Tachycardia
- Valvular Heart Disease
- Vasospastic Disease
Education
MD, Georgetown Univ. School of Medicine
Residency, Internal Medicine
New York Hospital Cornell University Med Ctr
Fellowship, Cardiology
Mount Sinai Hospital
Languages
English, Spanish
Mennell JS, Cesarman GM, Jacovina AT, Mclaughlin M, Lev EA, Hajjar KA. Annexin II and bleeding in acute promyelocytic leukemia. N Engl J Med 1991; 340: 994-1004.
Mclaughlin M, Fuster V. Three mechanisms for coronary artery disease progression; insights into future management. Mount Sinai Journal of Medicine 1995; 62(4): 265-274.
Mclaughlin M, Chesebro JH, Fuster V. Hypercoagulable states and. ACC Current Journal Review 1996 May / June;: 28-35.
Mclaughlin M, Phillips RA, Patel TN, Siu AL, David O, Buckley S, Mara T, Goldman ME. Prevalence and treatment patterns of diastolic filling abnormalities in the elderly. Journal of Heart Failure 1997; 4(1): 110.
Gersony DR, Mclaughlin M, Sacks HS, Fuster V, Gersony WM. Effect of beta blocker therapy on clinical outcome in patients with Marfans syndrome: Meta-analysis of data from 802 patients. JACC 1999; 33(2): 243.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.McLaughlin did not report having any of the following types of financial relationships with industry during 2017 and/or 2018: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website.
Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.